Physician profile
Michelle Whaley
NPI 1205370830
$60,527.26
in general payments reported to CMS, 2019-2025
8 companies · $46K in 2025
The $46K reported for 2025 was more than what 99% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,378 · 2022: $9,635 · 2023: $820 · 2024: $1,463 · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $46K · Travel and Lodging: $1,739 · Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $45,823.05 |
| Travel and Lodging | $1,738.50 |
| Food and Beverage | $953.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ceribell, INC. | $46,096.02 | 2025 | Pocket Eeg Device |
| Genentech USA, INC. | $8,354.98 | 2021-2024 | Activase |
| Medtronic, INC. | $5,223.66 | 2021-2025 | Linq II |
| Intuitive Surgical, INC. | $558.55 | 2022 | |
| Viz.Ai, INC. | $104.29 | 2021 | |
| Chiesi USA, INC. | $91.00 | 2025 | Cleviprex |
| Astrazeneca Pharmaceuticals Lp | $80.47 | 2021-2024 | Andexxa |
| W. L. Gore & Associates, INC. | $18.29 | 2024 | Gore Cardioform Septal Occluder |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Whaley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.